Our findings indicated distinct expression patterns for TACT markers in CRC compared with those in BC, with specific markers (e.g., KRT19, FOXA2, and SNAIL2) showing significant upregulation in CRC, whereas others (e.g., EPCAM, ERBB2, and MKI67) were downregulated. This evidence concerns the gene ERBB2 and breast cancer.